Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial-2 (MINT-2)"

NCT06702033 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT06702033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06702033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial-2 (MINT-2)"
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Recruiting
Start date
April 10, 2025
Completion date
July 15, 2033
Enrollment
142 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hpv-related oropharynx squamous cell carcinoma